{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:11:03Z","timestamp":1790291463641,"version":"4.1.0"},"reference-count":45,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,11,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The importance of telomere length to human health, aging, and cancer continues to be underappreciated. This review examines some basics of telomere biology and relates how telomere function, telomerase activity, and mutations in TERC or TERT are involved in bone marrow failure, leukemias, and other cancers. Given the challenge to obtain accurate data on telomerase activity and telomere length in specific cell types, the situation in acute myeloid leukemia (AML) remains puzzling. In most cancers, telomerase levels are increased after cells have encountered a \u201ctelomere crisis,\u201d which is typically associated with poor prognosis. Cells emerging from \u201ctelomere crisis\u201d have defective DNA damage responses, resulting, for example, from loss of p53. Such cells often express elevated telomerase levels as a result of point mutations in the TERT promoter or amplification of the TERT gene. While telomeres in AML blasts are typically shorter than expected for normal leukocytes, most AML cells do not show evidence of having gone through a \u201ctelomere crisis.\u201d In chronic myeloid leukemia (CML), the difference between the telomere length in nonmalignant T cells and malignant blasts from the same patient was found to correlate with the remaining duration of the chronic phase. This observation supports that a mitotic clock is ticking in CML stem cells and that disease progression in CML heralds the onset of a \u201ctelomere crisis.\u201d The presence of very short telomeres in tumor cells was found to predict disease progression in chronic lymphocytic leukemia, myeloma, and various solid tumors. In view of these findings longitudinal studies of telomere length in AML appear worthwhile.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017012112","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T08:16:23Z","timestamp":1570695383000},"page":"2467-2472","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":19,"title":["Maintenance of telomere length in AML"],"prefix":"10.1182","volume":"1","author":[{"given":"Peter M.","family":"Lansdorp","sequence":"first","affiliation":[{"name":"Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada; and European Research Institute for the Biology of Ageing, University of Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2017,11,28]]},"reference":[{"key":"2019111619481478700_B1","volume-title":"Blood Lines","author":"Metcalf","year":"2005"},{"key":"2019111619481478700_B2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jcp.1030620313","article-title":"The distribution of colony-forming cells among spleen colonies","volume":"62","author":"Siminovitch","year":"1963","journal-title":"J Cell Comp Physiol"},{"key":"2019111619481478700_B3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1073\/pnas.51.1.29","article-title":"A stochastic model of stem cell proliferation, based on the growth of spleen colony-forming cells","volume":"51","author":"Till","year":"1964","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019111619481478700_B4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.seminhematol.2016.10.004","article-title":"Age-associated changes in human hematopoietic stem cells","volume":"54","author":"Pang","year":"2017","journal-title":"Semin Hematol"},{"issue":"3","key":"2019111619481478700_B5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.178.3.787","article-title":"Ontogeny-related changes in proliferative potential of human hematopoietic cells","volume":"178","author":"Lansdorp","year":"1993","journal-title":"J Exp Med"},{"issue":"21","key":"2019111619481478700_B6","doi-asserted-by":"crossref","first-page":"9857","DOI":"10.1073\/pnas.91.21.9857","article-title":"Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age","volume":"91","author":"Vaziri","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"2019111619481478700_B7","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1101\/gad.1346005","article-title":"Shelterin: the protein complex that shapes and safeguards human telomeres","volume":"19","author":"de Lange","year":"2005","journal-title":"Genes Dev"},{"issue":"19","key":"2019111619481478700_B8","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1101\/gad.439107","article-title":"The nature of telomere fusion and a definition of the critical telomere length in human cells","volume":"21","author":"Capper","year":"2007","journal-title":"Genes Dev"},{"issue":"7147","key":"2019111619481478700_B9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/nature05976","article-title":"Replication and protection of telomeres","volume":"447","author":"Verdun","year":"2007","journal-title":"Nature"},{"issue":"5230","key":"2019111619481478700_B10","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1126\/science.7545310","article-title":"Telomerase and DNA end replication: no longer a lagging strand problem?","volume":"269","author":"Lingner","year":"1995","journal-title":"Science"},{"issue":"5820","key":"2019111619481478700_B11","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1126\/science.1138596","article-title":"Protein composition of catalytically active human telomerase from immortal cells","volume":"315","author":"Cohen","year":"2007","journal-title":"Science"},{"issue":"5955","key":"2019111619481478700_B12","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1126\/science.1170633","article-title":"How telomeres solve the end-protection problem","volume":"326","author":"de Lange","year":"2009","journal-title":"Science"},{"issue":"35","key":"2019111619481478700_B13","doi-asserted-by":"crossref","first-page":"E5125","DOI":"10.1073\/pnas.1607411113","article-title":"Structural conservation in the template\/pseudoknot domain of vertebrate telomerase RNA from teleost fish to human","volume":"113","author":"Wang","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2019111619481478700_B14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.cell.2016.01.036","article-title":"Shelterin protects chromosome ends by compacting telomeric chromatin","volume":"164","author":"Bandaria","year":"2016","journal-title":"Cell"},{"issue":"1-2","key":"2019111619481478700_B15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mrfmmm.2011.04.003","article-title":"Telomere length measurement-caveats and a critical assessment of the available technologies and tools","volume":"730","author":"Aubert","year":"2012","journal-title":"Mutat Res"},{"key":"2019111619481478700_B16","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0091-679X(04)75031-1","article-title":"Telomere length measurements using fluorescence in situ hybridization and flow cytometry","volume":"75","author":"Baerlocher","year":"2004","journal-title":"Methods Cell Biol"},{"issue":"5","key":"2019111619481478700_B17","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/nprot.2006.263","article-title":"Flow cytometry and FISH to measure the average length of telomeres (flow FISH)","volume":"1","author":"Baerlocher","year":"2006","journal-title":"Nat Protoc"},{"issue":"5","key":"2019111619481478700_B18","doi-asserted-by":"crossref","first-page":"e1002696","DOI":"10.1371\/journal.pgen.1002696","article-title":"Collapse of telomere homeostasis in hematopoietic cells caused by heterozygous mutations in telomerase genes","volume":"8","author":"Aubert","year":"2012","journal-title":"PLoS Genet"},{"issue":"3","key":"2019111619481478700_B19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1365-2141.2002.03910.x","article-title":"Telomere maintenance in human B lymphocytes","volume":"119","author":"Martens","year":"2002","journal-title":"Br J Haematol"},{"issue":"20","key":"2019111619481478700_B20","doi-asserted-by":"crossref","first-page":"10827","DOI":"10.1073\/pnas.94.20.10827","article-title":"Telomere lengthening and telomerase activation during human B cell differentiation","volume":"94","author":"Weng","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2019111619481478700_B21","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood-2007-09-084913","article-title":"Telomeres, stem cells, and hematology","volume":"111","author":"Lansdorp","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2019111619481478700_B22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1474-9726.2006.00254.x","article-title":"Longitudinal data on telomere length in leukocytes from newborn baboons support a marked drop in stem cell turnover around 1 year of age","volume":"6","author":"Baerlocher","year":"2007","journal-title":"Aging Cell"},{"issue":"10","key":"2019111619481478700_B23","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/oxfordjournals.humrep.a137889","article-title":"Blastocysts prepare for the race to be male","volume":"8","author":"Mittwoch","year":"1993","journal-title":"Hum Reprod"},{"issue":"4","key":"2019111619481478700_B24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0268-960X(03)00020-1","article-title":"Dyskeratosis congenita: its link to telomerase and aplastic anaemia","volume":"17","author":"Dokal","year":"2003","journal-title":"Blood Rev"},{"issue":"14","key":"2019111619481478700_B25","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa042980","article-title":"Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia","volume":"352","author":"Yamaguchi","year":"2005","journal-title":"N Engl J Med"},{"issue":"18","key":"2019111619481478700_B26","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1182\/blood-2014-05-526285","article-title":"Bone marrow failure and the telomeropathies","volume":"124","author":"Townsley","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2019111619481478700_B27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1152\/physrev.00026.2007","article-title":"Telomeres and aging","volume":"88","author":"Aubert","year":"2008","journal-title":"Physiol Rev"},{"issue":"1","key":"2019111619481478700_B28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.exphem.2010.10.001","article-title":"Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells","volume":"39","author":"Brassat","year":"2011","journal-title":"Exp Hematol"},{"issue":"6358","key":"2019111619481478700_B29","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1126\/science.aao0535","article-title":"Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism","volume":"357","author":"Chiba","year":"2017","journal-title":"Science"},{"issue":"7171","key":"2019111619481478700_B30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nature06358","article-title":"Characterizing the cancer genome in lung adenocarcinoma","volume":"450","author":"Weir","year":"2007","journal-title":"Nature"},{"issue":"6","key":"2019111619481478700_B31","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1182\/blood.V95.6.1883","article-title":"Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry","volume":"95","author":"Br\u00fcmmendorf","year":"2000","journal-title":"Blood"},{"issue":"2","key":"2019111619481478700_B32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/bjh.13023","article-title":"Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease","volume":"167","author":"Lin","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111619481478700_B33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/bjh.14643","article-title":"Telomere length is a critical determinant for survival in multiple myeloma","volume":"178","author":"Hyatt","year":"2017","journal-title":"Br J Haematol"},{"issue":"6","key":"2019111619481478700_B34","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.molonc.2015.02.003","article-title":"Telomere fusion threshold identifies a poor prognostic subset of breast cancer patients","volume":"9","author":"Simpson","year":"2015","journal-title":"Mol Oncol"},{"issue":"8","key":"2019111619481478700_B35","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/leu.2013.57","article-title":"Telomere length and telomerase complex mutations in pediatric acute myeloid leukemia","volume":"27","author":"Aalbers","year":"2013","journal-title":"Leukemia"},{"issue":"12","key":"2019111619481478700_B36","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1038\/sj.leu.2403177","article-title":"Telomerase is limiting the growth of acute myeloid leukemia cells","volume":"17","author":"R\u00f6th","year":"2003","journal-title":"Leukemia"},{"issue":"3","key":"2019111619481478700_B37","first-page":"307","article-title":"Telomere length and hTERT expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities","volume":"90","author":"Hartmann","year":"2005","journal-title":"Haematologica"},{"issue":"31","key":"2019111619481478700_B38","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2016.66.9622","article-title":"Shorter remission telomere length predicts delayed neutrophil recovery after acute myeloid leukemia therapy: a report from the Children\u2019s Oncology Group","volume":"34","author":"Gerbing","year":"2016","journal-title":"J Clin Oncol"},{"issue":"9","key":"2019111619481478700_B39","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s00277-017-3049-z","article-title":"Evidence for a pre-existing telomere deficit in non-clonal hematopoietic stem cells in patients with acute myeloid leukemia","volume":"96","author":"Ventura Ferreira","year":"2017","journal-title":"Ann Hematol"},{"issue":"2","key":"2019111619481478700_B40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.seminhematol.2017.04.004","article-title":"Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia","volume":"54","author":"Savage","year":"2017","journal-title":"Semin Hematol"},{"issue":"5","key":"2019111619481478700_B41","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1200\/JCO.2008.17.1033","article-title":"Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma","volume":"27","author":"Chakraborty","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6088","key":"2019111619481478700_B42","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1126\/science.1218370","article-title":"Wnt\/\u03b2-catenin signaling regulates telomerase in stem cells and cancer cells","volume":"336","author":"Hoffmeyer","year":"2012","journal-title":"Science"},{"issue":"31","key":"2019111619481478700_B43","doi-asserted-by":"crossref","first-page":"13842","DOI":"10.1073\/pnas.0913834107","article-title":"RNAi screen for telomerase reverse transcriptase transcriptional regulators identifies HIF1alpha as critical for telomerase function in murine embryonic stem cells","volume":"107","author":"Coussens","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019111619481478700_B44","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.devcel.2010.01.007","article-title":"Structural basis of selective ubiquitination of TRF1 by SCFFbx4","volume":"18","author":"Zeng","year":"2010","journal-title":"Dev Cell"},{"issue":"2","key":"2019111619481478700_B45","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/bjh.14666","article-title":"Telomere length is an independent prognostic marker in MDS but not in de novo AML","volume":"178","author":"Williams","year":"2017","journal-title":"Br J Haematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/25\/2467\/879456\/advances012112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/25\/2467\/879456\/advances012112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T00:48:36Z","timestamp":1573951716000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/25\/2467\/15771\/Maintenance-of-telomere-length-in-AML"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,28]]},"references-count":45,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2017,11,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017012112","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,28]]}}}